The FEDERATE-CAN trial: FEasibility and aDoption of a scrEening pRogrAm for Type 1 diabetes rElatives in CANada
Brief description
The IRCM clinic is looking for participants to take part in the FEDERATE research project. Our study, led by Dr. Remi Rabasa-Lhoret and his team, aims to investigate the feasibility and adoption of a screening program for early stages of type 1 diabetes among first-degree adult relatives (mother, father, brother, sister, child) of people living with type 1 diabetes in the province of Quebec.
Implication
The study involves up to eight (8) visits to the IRCM over a maximum of three (3) years. The first visit (inclusion visit), lasting two (2) hours, will allow you to sign the consent form, undergo a medical examination, perform a blood draw for screening of DT1 and other conditions (e.g. celiac disease) and answer questionnaires.
- If the screening test is negative (95% of cases), your participation will end at this stage, and no further follow-up visits are planned.
- If the screening test is positive, other visits will be planned to confirm the result of the first screening test. Then, you will be offered the option of being monitored by your family doctor or by Dr. Rabasa-Lhoret's team, depending on your preference. If you choose Dr. Rabasa-Lhoret's team, a maximum of six (6) follow-up visits spread over three (3) years will take place. Each visit will last a maximum of two (2) hours.
Inclusion Criteria
- Having a first-degree relative (mother, father, brother, sister, child) living with type 1 diabetes
- Not having been diagnosed with diabetes themselves
- Be between 18 to 65 years old
- Living in the province of Quebec
Information
Delphine Bouchard
514-987-5500 extension 3295
Email: delphine.bouchard@ircm.qc.ca
